FDA's Parting Blow: A Legacy of Controversy Under Makary The departure of Dr.
Marty Makary as FDA commissioner marks a significant development in an agency already grappling with internal dysfunction and leadership turmoil.
President Donald Trump has praised Makary as a "wonderful man," but the reality is that his tenure was marked by controversy, including high profile rejections of rare disease treatments and criticism from drugmakers, physicians, and patient groups.